Business Daily Media


ACN Business

Hitachi and Axcelead to start joint development of solutions for the efficient creation of next-generation biopharmaceuticals

  • Written by ACN Newswire - Press Releases
TOKYO, Apr 7, 2021 - (JCN Newswire) - Hitachi, Ltd. (TSE:6501) and Axcelead, Inc. today announced a comprehensive collaborative partnership to develop solutions contributing to the efficient creation of next-generation biopharmaceuticals with digital technology and a drug discovery platform. Hitachi has also invested in the Drug Discovery Gateway

Read more //?#

Writers Wanted



News Co Media

Content & Technology Connecting Global Audiences

More Information - Less Opinion